EMMA

Emmaus Life Sciences, Inc.

Insiders buying nowCIK 822370

Emmaus Life Sciences, Inc. insider trading

Insiders at Emmaus Life Sciences, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Lee Willis C (CEO · Director) buying $5.7K of EMMA, filed Sep 02, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

Bought on the open market
$18.1K
Sold
Insiders
1
Latest trade
Aug 28, 2026

From SEC filings · last 30 days

Recent EMMA insider transactions

  1. Lee Willis CCEO · Director

    Bought 94,767 sh at $0.06 · Aug 28, 2026

    $5.7K

    Filing
  2. Lee Willis CCEO · Director

    Bought 100,000 sh at $0.05 · Aug 31, 2026

  3. Lee Willis CCEO · Director

    Bought 50,000 sh at $0.05 · Aug 27, 2026

    $2.5K

    Filing
  4. Lee Willis CCEO · Director

    Bought 46,000 sh at $0.04 · Aug 25, 2026

    $1.8K

    Filing
  5. Lee Willis CCEO · Director

    Bought 170,000 sh at $0.01 · Aug 29, 2025

    $1.7K

    Filing
  6. Lee Willis CCEO · Director

    Bought 70,000 sh at $0.02 · May 30, 2025

    $1.4K

    Filing

SEC Form 4 data, Q3 2024 to Q2 2026

EMMA insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, one insider traded EMMA on the open market: 1 purchase worth $800 and 0 sales. In the last four quarters alone: no open-market trades at all.

QuarterBoughtSold
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024+$8001 buy
Largest purchase
+$800 of EMMA by Lim Seah H. (Director) on Sep 16, 2024.

Open-market transactions through Jun 30, 2026most recent first

  • Lim Seah H.

    Director

    +$800

    Sep 16, 2024

    20,000 sh · $0.04

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check EMMA — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

Emmaus Life Sciences, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

Questions

Are EMMA insiders buying or selling?
Between May 30, 2025 and Aug 28, 2026, 1 Emmaus Life Sciences, Inc. insider made 6 open-market purchases worth $18.1K and no sales, a net purchase of $18.1K.
How much EMMA stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 1 Emmaus Life Sciences, Inc. insider made 1 open-market purchase worth $800 and no sales. In the four quarters to Jun 30, 2026: no purchases and no sales. The largest purchase was Lim Seah H. buying $800 on Sep 16, 2024.
What was the largest recent EMMA insider trade?
Lee Willis C (CEO · Director) bought $5.7K of EMMA stock on Aug 28, 2026 at about $0.06 a share.
When did an insider last buy EMMA shares?
The most recent open-market purchase on file is Lee Willis C (CEO · Director) buying $5K on Aug 31, 2026. The largest purchase in the period was $5.7K by Lee Willis C.
Where does EMMA insider trading data come from?
From the Form 4 filings Emmaus Life Sciences, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

The week's real signals — open-market insider buys, cluster formations and what insiders did in EMMA and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.

Sign up free